![](https://d3ilqtpdwi981i.cloudfront.net/zz4e6lK487plu8caM7IWxEXorrA=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/d1/e2/7f/d1e27f71-bcc4-46e6-bf94-8e998b4d8fa1/thumbnail_BPFile_object.jpg)
Article
DC expressing transgene Foxp3 are regulatory APC
European Journal of Immunology
(2010)
Abstract
Tolerogenic DC and suppressive Foxp3(+) Treg play important roles in preventing autoimmunity and allograft rejection. We report that (adenovirus mediated) ectopic expression of Foxp3 in human DC (i.e. DC.Foxp3) yields an APC that severely limits T-cell proliferation and type-1 immune responses from the naïve, but not memory, pool of responder T cells in vitro. In marked contrast, the frequencies of type-2 and Treg responses were dramatically increased after stimulation of naïve T cells with DC.Foxp3 versus control DC. DC.Foxp3-induced CD4(+)CD25(+) Treg cells potently suppressed the proliferation of, and IFN-gamma production from, CD4(+) and CD8(+) responder T cells. Notably, the immunosuppressive biology of DC.Foxp3 was effectively normalized by addition of 1-methyl-tryptophan or neutralizing anti-TGF-beta1 Ab during the period of T-cell priming. These data suggest the potential utility of regulatory DC.Foxp3 and/or DC.Foxp3-induced CD4(+)CD25(+) Treg as translational agents for the amelioration or prevention of pathology in the setting of allograft transplantation and/or autoimmunity.
Disciplines
Publication Date
January, 2010
DOI
10.1002/eji.200939667
Citation Information
Michael Lipscomb. "DC expressing transgene Foxp3 are regulatory APC" European Journal of Immunology Vol. 40 Iss. 2 (2010) p. 480 - 493 Available at: http://works.bepress.com/michael-lipscomb/1/